EarningsQ2 2025 Earnings Report

Novavax (NVAX) Q2 2025 Earnings Report

0 Followers

MX:NVAX Q2 2025 EPS Results

Actual EPS$11.21

Consensus EPS$0.14

Beat/MissBeat by +$11.06

One Year Ago EPS$17.89

Actual Revenue$4.32B

Expected Revenue$2.76B

Beat/MissBeat by +$1.57B

YoY Revenue Growth-42.42%

QuarterQ2 2025

Date08/06/2025

TimeBefore Open

Conference CallWednesday, August 6, 2025

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-4.19 / -	-22.592	―
Aug 06, 2026	2026 (Q2)	-6.87 / -5.78	11.205	-151.61% (-16.99)
May 06, 2026	2026 (Q1)	-4.37 / -1.08	52.955	-102.05% (-54.04)
Feb 26, 2026	2025 (Q4)	-8.77 / 1.99	-9.217	121.57% (+11.21)
Nov 06, 2025	2025 (Q3)	-21.62 / -22.59	-13.736	-64.47% (-8.86)
Aug 06, 2025	2025 (Q2)	0.14 / 11.21	17.893	-37.37% (-6.69)
May 08, 2025	2025 (Q1)	-7.65 / 52.95	-18.977	379.05% (+71.93)
Feb 27, 2025	2024 (Q4)	-9.29 / -9.22	-26.026	64.58% (+16.81)
Nov 12, 2024	2024 (Q3)	-14.30 / -13.74	-22.772	39.68% (+9.04)
Aug 08, 2024	2024 (Q2)	30.18 / 17.89	10.483	70.69% (+7.41)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed